Asper Biogene ISO15189 accreditation extension 2026

The Estonian Standardization and Accreditation Center conducted a regular audit in 2026 and confirms that Asper Biogene OÜ meets the requirements of EVS-EN ISO 15189:2022 as a medical laboratory in the field of genetics. Into list of accredited tests were added:

  • Determination of thrombophilia-related changes using NGS analysis,
  • Determination of hypolactasia-related changes using NGS and Sanger analysis